Dimethylformamide → (5,6-Dihydro-benzo[h]quinazolin-2-yl)-phenyl-amine
Reaction equation
C[N:2]([CH:4]=[C:5]1[CH2:14][CH2:13][C:12]2[C:7](=[CH:8][CH:9]=[CH:10][CH:11]=2)[C:6]1=O)[CH3:3].[C:16]1([NH:22]C(N)=N)[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1.C[N:27](C=O)C>>[N:27]1[C:6]2[C:7]3[CH:8]=[CH:9][CH:10]=[CH:11][C:12]=3[CH2:13][CH2:14][C:5]=2[CH:4]=[N:2][C:3]=1[NH:22][C:16]1[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=1Participants
4
Procedure
A solution of 2-dimethylaminomethylene-3,4-dihydro-2H-naphthalen-1-one 100 mg in 5 ml DMF and 3 eq. of N-phenyl-guanidine was stirred at 110° C. for overnight, the product was purified by directly injecting the DMF reaction solution into prep HPLC.
Workup
- customthe product was purified
- customthe DMF reaction solution into prep HPLC
Sources & evidence
- ORD record
- ord-7d97d143fd4b4cb3bf0038a75ca7a530
- Source dataset
- uspto-grants-2010_04
- Patent number
- US07700609B2
Reaction notes
Loading…